AlloVir Inc (ALVR)
0.9596
+0.07
(+8.18%)
USD |
NASDAQ |
Nov 05, 16:00
0.9596
0.00 (0.00%)
After-Hours: 16:00
AlloVir Shareholders Equity (Quarterly): 120.29M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 120.29M |
| March 31, 2024 | 120.44M |
| December 31, 2023 | 145.78M |
| September 30, 2023 | 195.33M |
| June 30, 2023 | 229.11M |
| March 31, 2023 | 193.53M |
| December 31, 2022 | 224.52M |
| September 30, 2022 | 253.23M |
| June 30, 2022 | 158.14M |
| March 31, 2022 | 191.68M |
| Date | Value |
|---|---|
| December 31, 2021 | 225.27M |
| September 30, 2021 | 267.30M |
| June 30, 2021 | 302.47M |
| March 31, 2021 | 330.37M |
| December 31, 2020 | 353.06M |
| September 30, 2020 | 373.90M |
| June 30, 2020 | -71.29M |
| March 31, 2020 | 113.11M |
| December 31, 2019 | -51.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-71.29M
Minimum
Jun 2020
373.90M
Maximum
Sep 2020
193.41M
Average
195.33M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Protalix BioTherapeutics Inc | 28.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 130.99M |
| Total Liabilities (Quarterly) | 10.70M |